Cargando…
Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798134/ https://www.ncbi.nlm.nih.gov/pubmed/35117683 http://dx.doi.org/10.21037/tcr.2020.04.15 |
_version_ | 1784641726167646208 |
---|---|
author | Lesueur, Paul Kao, William Geffrelot, Julien Stefan, Dinu |
author_facet | Lesueur, Paul Kao, William Geffrelot, Julien Stefan, Dinu |
author_sort | Lesueur, Paul |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8798134 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87981342022-02-02 Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated? Lesueur, Paul Kao, William Geffrelot, Julien Stefan, Dinu Transl Cancer Res Editorial Commentary AME Publishing Company 2020-05 /pmc/articles/PMC8798134/ /pubmed/35117683 http://dx.doi.org/10.21037/tcr.2020.04.15 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Editorial Commentary Lesueur, Paul Kao, William Geffrelot, Julien Stefan, Dinu Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated? |
title | Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated? |
title_full | Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated? |
title_fullStr | Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated? |
title_full_unstemmed | Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated? |
title_short | Adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated? |
title_sort | adjuvant hypofractionated stereotactic radiotherapy after resection of single large brain metastasis in patients with oligo-metastatic disease: a strategy finally validated? |
topic | Editorial Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798134/ https://www.ncbi.nlm.nih.gov/pubmed/35117683 http://dx.doi.org/10.21037/tcr.2020.04.15 |
work_keys_str_mv | AT lesueurpaul adjuvanthypofractionatedstereotacticradiotherapyafterresectionofsinglelargebrainmetastasisinpatientswitholigometastaticdiseaseastrategyfinallyvalidated AT kaowilliam adjuvanthypofractionatedstereotacticradiotherapyafterresectionofsinglelargebrainmetastasisinpatientswitholigometastaticdiseaseastrategyfinallyvalidated AT geffrelotjulien adjuvanthypofractionatedstereotacticradiotherapyafterresectionofsinglelargebrainmetastasisinpatientswitholigometastaticdiseaseastrategyfinallyvalidated AT stefandinu adjuvanthypofractionatedstereotacticradiotherapyafterresectionofsinglelargebrainmetastasisinpatientswitholigometastaticdiseaseastrategyfinallyvalidated |